Who owns Urogen Pharma?
- Ticker: URGN
- CUSIP Number: m96088105
Tip: Access positions for across all investors
Analyze quarterly positions in Urogen Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Urogen Pharma stock
Who bought or sold Urogen Pharma this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 3.1M | $46M | 0% | Mar 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 2.6M | $39M | 0% | Mar 2024 |
|
Menora Mivtachim Holdings | 2.3M | $35M | 0% | Mar 2024 |
|
BlackRock | 1.7M | $26M | 43% | Mar 2024 |
|
Cowen And Company | 1.6M | $24M | 100% | Mar 2024 |
|
Adage Capital Partners GP | 1.3M | $20M | 100% | Mar 2024 |
|
Credit Suisse | 1.2M | $18M | 0% | Mar 2024 |
|
Point72 Asset Management | 1.1M | $17M | 783% | Mar 2024 |
|
Leucadia National Corporation | 840k | $13M | 100% | Mar 2024 |
|
Migdal Insurance & Financial Holdings | 687k | $10M | 6% | Mar 2024 |
|
Harel Insurance Investments & Financial Services | 674k | $10M | -23% | Mar 2024 |
|
Morgan Stanley | 391k | $6.6M | 251% | Mar 2024 |
|
Geode Capital Management | 324k | $4.9M | 48% | Mar 2024 |
|
Superstring Capital Management | 288k | $4.3M | 13% | Mar 2024 |
|
Opaleye Management | 270k | $4.1M | -16% | Mar 2024 |
|
T. Rowe Price Associates | 267k | $4.0M | 100% | Mar 2024 |
|
Laurion Capital Management | 251k | $3.8M | 0% | Mar 2024 |
|
Northern Trust | 233k | $3.5M | 31% | Mar 2024 |
|
Wells Fargo & Company | 212k | $3.2M | -3% | Mar 2024 |
|
Vanguard Group | 195k | $2.9M | 14% | Mar 2024 |
|
Parkman Healthcare Partners | 184k | $2.8M | 27% | Mar 2024 |
|
ARK Investment Management | 146k | $2.2M | -9% | Mar 2024 |
|
AlphaCentric Advisors | 144k | $2.2M | -13% | Mar 2024 |
|
Goldman Sachs Group | 114k | $1.7M | 0% | Mar 2024 |
|
Citadel Advisors | 112k | $1.7M | -38% | Mar 2024 |
|
Wellington Management Company | 105k | $1.6M | 49% | Dec 2023 |
|
Schonfeld Strategic Advisors | 104k | $1.6M | -21% | Mar 2024 |
|
Nuveen Asset Management | 83k | $1.3M | 31% | Mar 2024 |
|
Annandale Capital | 82k | $1.2M | 0% | Dec 2023 |
|
Two Sigma Investments | 81k | $1.2M | -38% | Mar 2024 |
|
Susquehanna International | 79k | $1.2M | 50% | Mar 2024 |
|
De Lisle Partners | 77k | $1.2M | 100% | Mar 2024 |
|
Cibc World Markets | 75k | $1.1M | 100% | Mar 2024 |
|
Ameriprise Financial | 71k | $1.1M | -18% | Mar 2024 |
|
Rice Hall James & Associates | 70k | $1.1M | 1% | Mar 2024 |
|
Bank of New York Mellon | 68k | $1.0M | -3% | Mar 2024 |
|
Squarepoint Ops | 63k | $946k | 6% | Mar 2024 |
|
Charles Schwab Investment Management | 63k | $943k | 0% | Mar 2024 |
|
Oak Ridge Investments | 61k | $918k | 100% | Mar 2024 |
|
Bank of America Corporation | 53k | $796k | -26% | Mar 2024 |
|
UBS Group | 43k | $643k | 71% | Mar 2024 |
|
AQR Capital Management | 42k | $634k | 130% | Mar 2024 |
|
Millennium Management | 42k | $628k | -90% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 40k | $597k | 73% | Mar 2024 |
|
LLBH Private Wealth Management | 37k | $555k | -2% | Mar 2024 |
|
HPM Partners | 37k | $555k | -70% | Mar 2024 |
|
Meitav Dash Investments | 37k | $552k | -60% | Mar 2024 |
|
Rhumbline Advisers | 37k | $552k | 6% | Mar 2024 |
|
Robert Bender & Associates | 35k | $521k | 0% | Mar 2024 |
|
Jump Financial | 33k | $500k | 13% | Dec 2023 |
|
Shikiar Asset Management | 33k | $499k | 0% | Mar 2024 |
|
TD Asset Management | 33k | $492k | 100% | Mar 2024 |
|
Toroso Investments | 28k | $425k | 100% | Mar 2024 |
|
BBR Partners | 26k | $390k | 0% | Mar 2024 |
|
Balyasny Asset Management | 25k | $375k | 100% | Mar 2024 |
|
Palo Alto Investors | 25k | $368k | 0% | Mar 2024 |
|
Jane Street | 22k | $336k | 35% | Mar 2024 |
|
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet | 22k | $327k | 0% | Mar 2024 |
|
Vivaldi Capital Management | 20k | $256k | 22% | Mar 2024 |
|
Barclays | 19k | $291k | -48% | Mar 2024 |
|
Two Sigma Advisers | 19k | $282k | 3% | Mar 2024 |
|
Jpmorgan Chase & Co | 18k | $265k | -26% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 16k | $243k | -65% | Mar 2024 |
|
GSA Capital Partners | 15k | $224k | 100% | Mar 2024 |
|
MetLife Investment Advisors | 15k | $219k | 41% | Dec 2023 |
|
American International | 14k | $203k | 38% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 13k | $196k | 26% | Mar 2024 |
|
Engineers Gate Manager | 13k | $190k | 100% | Mar 2024 |
|
Federated Investors | 12k | $176k | -11% | Dec 2023 |
|
Royal Bank of Canada | 12k | $174k | -44% | Mar 2024 |
|
Ethos Financial Group | 11k | $158k | 0% | Mar 2024 |
|
Soleus Capital Management | 10k | $150k | 100% | Mar 2024 |
|
New York State Common Retirement Fund | 8.9k | $134k | 4% | Mar 2024 |
|
Cubist Systematic Strategies | 6.2k | $92k | 4231% | Mar 2024 |
|
China Universal Asset Management | 5.9k | $89k | 65% | Mar 2024 |
|
Allspring Global Investments Holdings | 5.0k | $74k | 0% | Mar 2024 |
|
Citigroup | 4.8k | $73k | -74% | Mar 2024 |
|
FMR | 3.2k | $49k | -34% | Mar 2024 |
|
Summit Investment Advisors | 2.8k | $42k | 0% | Mar 2024 |
|
Simplex Trading | 2.8k | $42k | -58% | Mar 2024 |
|
California State Teachers Retirement System | 2.8k | $42k | -35% | Mar 2024 |
|
Legal & General Group | 2.8k | $42k | -3% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.6k | $24k | 47% | Dec 2023 |
|
First Manhattan | 1.5k | $23k | 50% | Mar 2024 |
|
Public Employees' Retirement Association of Colorado | 1.4k | $21k | -88% | Mar 2024 |
|
Amalgamated Bank | 943.00 | $14k | -71% | Mar 2024 |
|
Advisor Group Holdings | 663.00 | $9.9k | 0% | Mar 2024 |
|
Signature | 650.00 | $9.8k | 6% | Mar 2024 |
|
Pnc Financial Services | 543.00 | $8.1k | 54200% | Mar 2024 |
|
Atlantic Trust | 509.00 | $7.2k | 100% | Mar 2024 |
|
Nbc Securities | 437.00 | $6.0k | 100% | Mar 2024 |
|
Lazard Asset Management | 354.00 | $5.0k | -89% | Dec 2023 |
|
Russell Investments | 253.00 | $3.8k | 0% | Mar 2024 |
|
Tower Research Capital | 187.00 | $2.8k | -98% | Mar 2024 |
|
Lindbrook Capital | 160.00 | $2.4k | 158% | Mar 2024 |
|
Us Bancorp | 134.00 | $2.0k | 0% | Mar 2024 |
|
EverSource Wealth Advisors | 57.00 | $855.000000 | 0% | Mar 2024 |
|
SYSTM Wealth Solutions | 48.00 | $720.000000 | 100% | Mar 2024 |
|
Daiwa Securities Group | 48.00 | $999.998400 | 0% | Mar 2024 |
|
CWM | 41.00 | $999.998200 | 100% | Mar 2024 |
|
Quadrant Capital | 26.00 | $390.000000 | -54% | Mar 2024 |
|
GAMMA Investing | 20.00 | $300.000000 | 100% | Mar 2024 |
|
NISA Investment Advisors | 17.00 | $255.000000 | 100% | Mar 2024 |
|
Farther Finance Advisors | 6.00 | $85.000200 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 4.00 | $60.000000 | 100% | Mar 2024 |
|
Who sold out of Urogen Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Clal Insurance Enterprises Holdings | Sep 2023 | 222k | $3.1M |
Eudaimonia Asset Management | Sep 2023 | 171k | $2.4M |
D. E. Shaw & Co | Dec 2023 | 78k | $1.2M |
Marshall Wace | Dec 2023 | 29k | $428k |
Walleye Trading Advisors | Dec 2023 | 27k | $408k |
Verition Fund Management | Sep 2023 | 17k | $238k |
Partners Capital Investment Group | Dec 2023 | 15k | $231k |
Sierra Summit Advisors | Dec 2023 | 15k | $218k |
Mirae Asset Global Investments | Dec 2023 | 11k | $170k |
SG Americas Securities | Dec 2023 | 8.7k | $131k |
Acadian Asset Management | Sep 2023 | 4.6k | $63k |
Cutler | Dec 2023 | 1.6k | $5.0k |